peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

antimicrobial peptide

Pexiganan

Published evidence · coverage incomplete
Anatomical contextAnatomy connections are not mapped yet.

No body region is highlighted until this profile has a supported anatomical connection. This does not mean the peptide has no biological effects.

Read published mechanism findings ↓

At a glance

What is it—and why does it matter?

Pexiganan is identified as a derivative of the antimicrobial peptide Magainin II, and it is designated MSI-78 in this work.

Sources for this introduction: [1]

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

Identity

Pexiganan is identified as a derivative of the antimicrobial peptide Magainin II, and it is designated MSI-78 in this work.

Sources[1]pubmedUnveiling the Potential of Magainin Derivatives against Candida Species.Antimicrobial peptides are promising alternative antimicrobial agents, but most work focuses on antibacterial studies, including Magainin II and its derivative Pexiganan (MSI-78).
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “Antimicrobial peptides are promising alternative antimicrobial agents, but most work focuses on antibacterial studies, including Magainin II and its derivative Pexiganan (MSI-78).”

    Unveiling the Potential of Magainin Derivatives against Candida Species. · Abstract

    pubmed:42593921:41e70dd79a5b:41e70dd79a5b

How does it work?

Target, response, and disposition.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

What has been studied?

What the evidence says.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
  • 6 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (6), extraction_ambiguity (6), no_direct_support (6)

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. Unveiling the Potential of Magainin Derivatives against Candida Species. ↗

    pubmed · published 2026-08-13 · retrieved 2026-08-27T11:48:55Z

Publication history and provenance

Version 2 · Automated assessment · 2026-08-27T11:48:55Z

45e05f045e35f7e8617ad81ba348e25e29cc638d58330020ae170fe5e63473f8